Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Elneima (Leicester, United Kingdom), T. Cao (Leicester, United Kingdom), H. Mcauley (Leicester, United Kingdom), M. Ramsheh (Leicester, United Kingdom), V. Mistry (Leicester, United Kingdom), N. Greening (Leicester, United Kingdom), L. Ng (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom). Mass spectrometry proteomic biomarkers identify acute COPD exacerbations. 2989

Member's Comments

No comment yet.

Related content which might interest you: Metabolomic fingerprinting in the identification of biomarkers in COPD patients Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008 A liquid chromatography MS/MS metabolomics study of COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Metabolic profiling detects biomarkers of protein degradation in COPD patients Source: Eur Respir J 2012; 40: 345-355 Year: 2012 SELDI-TOF biomarkers signatures for cystic fibrosis, asthma and COPD Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013 SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Metabolomics identifies biomarkers of exacerbations in smokers with and without COPD Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Breath analysis by ion mobility spectrometry in COPD and lung cancer patients Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 Expiratory gas analysis using mass spectrometry in chronic obstructive pulmonary disease Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Development of mass spectrometry approaches to quantifying lipid mediators in airway disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018 Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Preliminary proteomics analysis for sepsis biomarkers with iTRAQ labeling and LC-MS/MS Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Identification of novel diagnostic biomarkers of chronic thromboembolic pulmonary hypertension using MALDI-TOF-MS Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Application of omics technologies to the identification of biomarkers for COPD Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring Source: Eur Respir J 2006; 28: Suppl. 50, 152s Year: 2006 A NMR-based metabolomics approach to the assessment of inhaled pharmacotherapy in patients with COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019